Month: May 2023

Tortola, British Virgin Islands , May 15, 2023 (GLOBE NEWSWIRE) — SEALSQ Announces Upcoming Listing of Its Ordinary Shares on the Nasdaq Global Market Tortola, British Virgin Islands – May 15, 2023: SEALSQ Corp (“SEALSQ”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products is pleased to announce that the Nasdaq Stock Market LLC has approved SEALSQ’s application to list its Ordinary Shares on the Nasdaq Global Market. SEALSQ is a subsidiary of WISeKey International Holding Ltd (NASDAQ: WKEY / SIX: WIHN) (“WISeKey”), a leading Swiss cybersecurity and IoT company. As previously announced, on April 27, 2023, WISeKey shareholders approved a special dividend-in-kind to be paid to all of its shareholders in the form of shares in SEALSQ (subject to certain approvals).   SEALSQ...

TECO 2030 ASA (OSE-Ticker: TECO) plans to establish Norway’s first large-scale production of hydrogen-based fuel cells in Narvik in Northern Norway. Fuel cells enable ships and other heavy-duty applications to switch from fossil fuels such as heavy oil and diesel to climate-friendly hydrogen, and thereby reduce greenhouse gas emissions from the shipping industry.Stack0001Narvik The first ever TECO 2030 fuel cell stack built in Narvik.TECO 2030 Fuel Cells On the left is an illustration of Implenia’s HydroPilot container and on the right is HyEkoTank project for Tarbit Shipping and Shell.Cutting the ribbon Rune Karlsen (right), Managing Director at TECO 2030 Innovation Center, cutting the ribbon together with Ingrid Martenson Bortne (left) from Innovation Norway at the giga factory opening ceremony. Photo:...

REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s website Mont-Saint-Guibert, Belgium, May 15th, 2023 7.00am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases and cell repair, invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the Annual General Meeting to be held on Wednesday 14 June 2023 as from 4:00 pm CEST, at Osborne Clarke offices, Bastion Tower, Place du Champ de Mars 5, 1050 Brussels, Belgium. The notices for the meetings, including the agenda of the day as well as the motions to vote, are published today in the Belgian Official Gazette and La Libre Belgique. The documents and preliminary information concerning...

AB Linas Agro Group, ISIN code LT0000128092 (hereinafter – the Company), received notification from the Company’s executives regarding the transactions in the Company’s securities (enclosed).   Additional information: Mažvydas Šileika, Finance Director of AB Linas Agro Group Mob. +370 619 19 403 E-mail m.sileika@linasagro.lt  Attachment2023-05-15_Notification on manager transactions_A.Pranckevicius

Novartis Board of Directors approves the recommendation of Sandoz Chairman-designate for the future Sandoz Board of Directors, to start preparatory work in June, followed by formal constitution in H2 2023 Experienced and diverse group of corporate leaders with a track record of growing businesses and driving value for the organization and society will help set strategic direction for Sandoz and support its future developmentBasel, May 15, 2023 — Sandoz takes the next steps to prepare for the planned listing on the Swiss Stock Exchange (SIX): The Novartis Board of Directors has approved the recommendations of the Sandoz Chairman-designate, Gilbert Ghostine, on the structure of the to-be Board of Directors of Sandoz and has nominated all of its future members. The Sandoz Board of Directors will have 10 members in total and 3 sub-committees:...

TORONTO, May 14, 2023 (GLOBE NEWSWIRE) — Toubani Resources Inc (ASX:TRE) (“Toubani Resources” or the “Company”) is pleased to announce the appointments of Mr Scott Perry and Mr Mark Strizek to the Board as Non-Executive Directors, effective today. Mr Perry and Mr Strizek are both highly experienced senior mining executives in the industry with a proven track record in corporate initiatives and advancement of development stage assets. Non-Executive Directors Mr Jan-Erik Back and Mr Doug Jendry are retiring from the Board, effective today. Accordingly, the Toubani Board of Directors now consists of Danny Callow as Executive Chairman, Tim Kestell, Scott Perry and Mark Strizek as Non-Executive Directors, and Phil Russo as Chief Executive Officer and Executive Director. Mr Callow, as previously planned, will transition to Non-Executive...

To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and Fulfill APD Customer Orders During Process BUFFALO, N.Y., May 14, 2023 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX) (“Athenex” or the “Company”), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that, following an ongoing strategic review, it has reached agreement with its lenders to move forward with an expedited sales process of the Company’s assets across its primary businesses: Athenex Pharmaceutical Division (“APD”), Orascovery, and Cell Therapy. To best facilitate this process, Athenex and certain of its subsidiaries filed voluntary...

COPENHAGEN, Denmark, May 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced the company will present clinical and research outcomes in hypoparathyroidism and growth hormone deficiency, and host informational booth and events, at ECE 2023, the European Congress of Endocrinology being held May 13-16 in Istanbul, Turkey. ECE gathers international professionals to share the latest science and clinical practice across the fields of endocrinology and metabolism. “Ascendis is committed to creating novel therapies with best-in-class safety, efficacy, tolerability, and convenience,” said Jan Mikkelsen, Ascendis Pharma’s President and Chief Executive Officer. “We are pleased to showcase our advancing Endocrinology portfolio, the meaningful differences we are making for patients, and our work to bring new treatment...

Prospera Energy Inc. PEI: TSX-V; OF6A: FRA, OTC: GXRFF CALGARY, Alberta, May 12, 2023 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“Prospera” or the “Corporation“) (PEI: TSX-V; OF6A: FRA; GXRFF: OTC) announces that further to its news release dated April 28, 2023, the Corporation’s principal regulator, the Alberta Securities Commission (the “ASC“) granted a management cease trade order (the “MCTO”) on May 4, 2023, under National Policy 12-203 Management Cease Trade Orders (“NP 12-203”). Pursuant to the MCTO, Samuel David, the Chief Executive Officer, and Matthew Kenna, the Chief Financial Officer, may not trade in securities of the Corporation until such time as the Corporation files its annual audited financial statements, annual management’s discussion and analysis...